ARISE: 1600 patients with septic shock at 51 sites in Australia and New Zealand ProCESS: 1341 patients with septic shock at 31 U.S. sites ProMISe: 1260 patients with septic shock at 56 U.K. sites ...
Purpose. The efficacy and safety of granulocyte colony-stimulating factor (G-CSF) in critically ill patients with severe sepsis or septic shock were evaluated. Summary. The medical literature was ...
Background: Septic shock, the most severe stage of sepsis, causes potential circulatory failure and abnormal cell metabolism which are severe enough to affect prognosis, increase mortality, and impose ...